Related Experiment Video
Updated: Jul 20, 2025

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
Published on: February 28, 2021
Evaluation of an optimized germline exomes pipeline using BWA-MEM2 and Dragen-GATK tools
Nofe Alganmi1,2, Heba Abusamra2
1Department of Computer Science, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah, Saudi Arabia.
Abstract:
The next-generation sequencing (NGS) technology represents a significant advance in genomics and medical diagnosis. Nevertheless, the time it takes to perform sequencing, data analysis, and variant interpretation is a bottleneck in using next-generation sequencing in precision medicine. For accurate and efficient performance in clinical diagnostic lab practice, a consistent data analysis pipeline is necessary to avoid false variant calls and achieve optimum accuracy. This study aims to compare the performance of two NGS data analysis pipeline compartments, including short-read mapping (BWA-MEM and BWA-MEM2) and variant calling (GATK-HaplotypeCaller and DRAGEN-GATK). On Whole Exome Sequencing (WES) data, computational performance was assessed using several criteria, including mapping efficiency, variant calling performance, false positive calls rate, and time. We examined four gold-standard WES data sets: Ashkenazim father (NA24149), Ashkenazim mother (NA24143), Ashkenazim son (NA24385), and Asian son (NA25631). In addition, eighteen exome samples were analyzed based on different read counts, and coverage was used precisely in the run-time assessment. By using BWA-MEM 2 and Dragen-GATK, this study achieved faster and more accurate detection for SNVs and indels than the standard GATK Best Practices workflow. This systematic comparison will enable the bioinformatics community to develop a more efficient and faster solution for analyzing NGS data.
More Related Videos
11:02Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023